Table 1 Baseline characteristics
Variable | Whole (n = 63) |
|---|---|
Baseline characteristics | |
Age, year | 41 ± 12 |
Male gender | 43 (68.3) |
Body mass index > 25 | 21 (33.3) |
Comorbidities | |
Hypertension | 32 (50.8) |
Smoking | 21 (33.3) |
Coronary artery disease | 0 (0) |
Prior stroke | 0 (0) |
Marfan syndrome | 39 (61.9) |
Prior re-TEVAR | 26 (41.3) |
Indications for prior TEVAR | |
Residue type I dissection | 17 (27.0) |
Type III dissection | 42 (66.7) |
Aortic ulcer | 1 (1.6) |
Aortic rupture | 3 (4.8) |
Prior proximal aortic surgery | |
Bentall operation | 24 (38.1) |
Ascending aortic replacement | 6 (9.5) |
Prior total arch replacement + frozen elephant trunk | 11 (17.5) |
Endoleak | 22 (34.9) |
Type I endoleak | 18 (28.6) |
I a | 6 (9.5) |
I b | 6 (9.5) |
I a + I b | 6 (9.5) |
Type II endoleak | 4 (6.3) |
Persisted false lumen perfusion | 36 (57.1) |
Aortic rupture | 9 (14.3) |
Pathology of aneurysms | |
Degenerative | 3 (4.8) |
Post-dissection | 60 (95.2) |
The interval between TEVAR and TAAAR, year | 2.6 (1.2–6.1) |
Maximum distal aortic size, mm | 71 ± 22 |
Positive intercostal artery angiogram | 33 (52.4) |
Extent of TAAA | |
I | 9 (14.3) |
II | 22 (34.9) |
III | 23 (36.5) |
IV | 9 (14.3) |